drugset
drugset / Trial / NCT04594681

A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration

NCT04594681 ↗

Phase 1 Terminated 116 enrolled Kyowa Kirin, Inc.
RandomizedSequentialQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate safety and tolerability after administration of KHK4951 in healthy volunteers and patients with wet age-related macular degeneration.

Timeline

Start
2020-09-16
Primary completion
2022-08-26
Completion
2022-08-26

Drugs

EvaluationDrugModalityDoseRoute
Subject KHK4951 Unknown — —

Indications

wet macular degeneration